Humana (NYSE:HUM) Shares Down 2.9% - Time to Sell?

Humana Inc. (NYSE:HUM - Get Free Report) shares were down 2.9% during mid-day trading on Monday . The company traded as low as $288.00 and last traded at $286.51. Approximately 153,686 shares traded hands during mid-day trading, a decline of 91% from the average daily volume of 1,746,191 shares. The stock had previously closed at $295.04.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on HUM. Truist Financial lifted their price objective on Humana from $290.00 to $325.00 and gave the company a "hold" rating in a report on Friday, April 11th. Royal Bank of Canada restated an "outperform" rating and issued a $283.00 price target on shares of Humana in a research report on Wednesday, February 12th. Barclays raised their price objective on shares of Humana from $270.00 to $322.00 and gave the stock an "equal weight" rating in a report on Friday, April 11th. Piper Sandler raised their price target on Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a report on Wednesday, January 15th. Finally, Guggenheim started coverage on Humana in a report on Wednesday, April 9th. They set a "buy" rating and a $326.00 target price on the stock. Seventeen equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, Humana currently has a consensus rating of "Hold" and a consensus price target of $284.90.

Humana Stock Performance

The stock has a 50 day moving average price of $265.90 and a two-hundred day moving average price of $269.86. The company has a market cap of $31.91 billion, a P/E ratio of 26.57, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, research analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.34%. Humana's dividend payout ratio is 35.58%.

Hedge Funds Weigh In On Humana

Several hedge funds and other institutional investors have recently made changes to their positions in HUM. FPC Investment Advisory Inc. bought a new position in Humana in the fourth quarter valued at approximately $27,000. Centricity Wealth Management LLC acquired a new stake in shares of Humana in the 4th quarter valued at $30,000. LFA Lugano Financial Advisors SA increased its stake in shares of Humana by 56.3% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after purchasing an additional 45 shares during the last quarter. OFI Invest Asset Management acquired a new position in shares of Humana during the 4th quarter worth $33,000. Finally, Riverview Trust Co bought a new stake in shares of Humana during the 1st quarter worth $34,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.